Markenrecherche nach Bristol-Myers Squibb · TMDB

Marken vergleichen

Ihre Suche hat mehr als 1000 Treffer ergeben. Bitte filtern Sie die Ergebnisse, um die Anzahl der Treffer zu reduzieren.

Klasse(n)

1641

Bristol-Myers Squibb Company

19.11.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

THE BE-LOW STUDY

42

Bristol-Myers Squibb Company

15.11.2010

-

-

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

VIK VERY IMPORTANT KIDS

42

Bristol-Myers Squibb Company

09.11.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

AUTISM LET'S TALK ABOUT IT CLINICAL RESEARCH TRIAL

42

Bristol-Myers Squibb Company

09.11.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

ACCOMPANY - ABATACEPT IN SUBJECTS WITH RHEUMATOID ARTHRITIS ADMINISTERED PLUS OR MINUS BACKGROUND METHOTREXATE SUBCUTANEOUSLY

42

Bristol-Myers Squibb Company

29.10.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

ATTUNE - ABATACEPT IN SUBJECTS WHO SWITCH FROM INTRAVENOUS TO SUBCUTANEOUS THERAPY

42

Bristol-Myers Squibb Company

29.10.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

ALLOW- EVALUATION OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY IN ADULTS WITH ACTIVE RHEUMATOID ARTHRITIS; IMPACT OF WITHDRAWAL AND REINTRODUCTION ON IMMUNOGENICITY, EFFICACY AND SAFETY

42

Bristol-Myers Squibb Company

29.10.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

ACQUIRE- ABATACEPT COMPARISON OF SUB(QU)CUTANEOUS VS. INTRAVENOUS IN INADEQUATE RESPONDERS TO METHOTREXATE

42

Bristol-Myers Squibb Company

29.10.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

THETYPE2TALK.COM CHANGING THE TYPE 2 DIABETES CONVERSATION

1641

Bristol-Myers Squibb Company

20.10.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

1641

Bristol-Myers Squibb Company

18.10.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

Darum lohnt sich ein kostenfreier TMDB Account

Marken überwachen und schützen

Wenn Sie eine Markenüberwachung eingerichtet haben, erhalten Sie automatisch eine E-Mail über Nachahmer und Trittbrettfahrer. So funktioniert unkomplizierter Markenschutz in Echtzeit.

Marken ganz einfach folgen

Wenn Sie einer Marke folgen, erhalten Sie eine E-Mail bei neuen Anmeldungen, Widersprüchen, Fristen und Verlängerungen u.v.m. – So bleiben Sie auf dem Laufenden was die Entwicklung einer Marke angeht.

Kostenfrei registrieren

5

Bristol-Myers Squibb Company

29.09.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

SPRING SUPPORT, PATIENT RESOURCES, INFORMATION AND GUIDANCE

16

Bristol-Myers Squibb Company

29.09.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

BE MELANOMA SMART

1641

Bristol-Myers Squibb Company

27.09.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

16.09.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

42

Bristol-Myers Squibb Company

15.09.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

07.09.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

42

Adnexus, a Bristol-Myers Squibb R&D Company

23.08.2010

-

-

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

5

Bristol-Myers Squibb Company

17.08.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

CML TREATMENT COMPANION

41

Bristol-Myers Squibb Company

11.08.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

06.08.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

06.08.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

06.08.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

06.08.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

06.08.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

06.08.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

06.08.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

05.08.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

05.08.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

01.07.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

01.07.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

BRISTOL-MYERS SQUIBB COMPANY

23.06.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

MANAGE TYPE 2 TODAY

1641

Bristol-Myers Squibb Company

23.06.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

DEMONSTRATE: DRUG EVALUATION IN MELANOMA: ONCOLOGY STUDY AND RESEARCH OF IPILIMUMAB

42

Bristol-Myers Squibb Company

16.06.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

ASIDE: A PHASE IIIB, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY AND INTRAVENOUSLY IN SUBJECTS WITH RHEUMATOID ARTHRITIS, RECEIVING BACKGROUND METHOTREXATE, AND EXPERIENCING AN INADEQUATE RESPONSE TO METHOTREXATE

42

Bristol-Myers Squibb Company

15.06.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

IDEATE: IPILIMUMAB DRUG EVALUATION

42

Bristol-Myers Squibb Company

14.06.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

1641

Bristol-Myers Squibb Company

07.06.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

D- LITE - DIRECT ACTING ANTIVIRALS LAMBDA INTERFERON TREATMENT EVALUATION

42

Bristol-Myers Squibb Company

27.05.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

24.05.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

24.05.2010

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Bristol-Myers Squibb Company

21.05.2010

-

-

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

Suchergebnisse 761 - 801 von 1000+

Wir lieben Marken.
Und betreuen Sie gerne.

Sie erreichen uns von Montag bis Freitag zwischen 08:00–16:00 Uhr.

Kontaktieren Sie uns.